These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 3908316

  • 21. Sodium and responses to infused noradrenaline and angiotensin II in subjects predisposed to hypertension.
    Pusterla C, Beretta-Piccoli C, Städler P, Weidmann P, Shaw S.
    J Hum Hypertens; 1988 Mar; 1(4):267-76. PubMed ID: 3065505
    [Abstract] [Full Text] [Related]

  • 22. Cardiovascular regulation during administration of co-dergocrine to normal subjects.
    Gerber A, Weidmann P, Laederach K.
    Eur J Clin Pharmacol; 1986 Mar; 29(5):565-72. PubMed ID: 3956562
    [Abstract] [Full Text] [Related]

  • 23. Blood pressure control in normotensive members of hypertensive families.
    Bianchetti MG, Beretta-Piccoli C, Weidmann P, Ferrier C.
    Kidney Int; 1986 Apr; 29(4):882-8. PubMed ID: 3520094
    [Abstract] [Full Text] [Related]

  • 24. Calcium and blood pressure regulation in normal and hypertensive subjects.
    Bianchetti MG, Beretta-Piccoli C, Weidmann P, Link L, Boehringer K, Ferrier C, Morton JJ.
    Hypertension; 1983 Apr; 5(4 Pt 2):II57-65. PubMed ID: 6345376
    [Abstract] [Full Text] [Related]

  • 25. Antihypertensive mechanism of the diuretic muzolimine in mild renal failure. Roles of sodium and cardiovascular norepinephrine responsiveness.
    Schiffl H, Weidmann P, Beretta-Piccoli C, Cottier C, Seiler AJ, Ziegler WH.
    Eur J Clin Pharmacol; 1982 Apr; 23(3):215-20. PubMed ID: 6756933
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Neural control of circulation before and after intravenous urapidil in essential hypertension.
    Grassi G, Parati G, Pomidossi G, Giannattasio G, Casadei R, Groppelli A, Zanchetti A, Mancia G.
    Drugs; 1988 Apr; 35 Suppl 6():104-10. PubMed ID: 3402353
    [Abstract] [Full Text] [Related]

  • 28. Systemic haemodynamic and humoral changes during urapidil treatment in hypertensive patients.
    Leonetti G, Terzoli L, Zanchetti A.
    J Hypertens Suppl; 1988 Dec; 6(2):S25-9. PubMed ID: 2906697
    [Abstract] [Full Text] [Related]

  • 29. [The effect of urapidil on blood pressure, renal hemodynamics, lipid and glucose metabolism].
    Sanjuliani AF, Fagundes VG, Francischetti EA.
    Arq Bras Cardiol; 1995 Jul; 65(1):59-63. PubMed ID: 8546598
    [Abstract] [Full Text] [Related]

  • 30. Norepinephrine-related mechanism in hypertension accompanying renal failure.
    Schohn D, Weidmann P, Jahn H, Beretta-Piccoli C.
    Kidney Int; 1985 Nov; 28(5):814-22. PubMed ID: 4087696
    [Abstract] [Full Text] [Related]

  • 31. Enhanced cardiovascular pressor reactivity to norepinephrine in mild renal parenchymal disease.
    Beretta-Piccoli C, Weidmann P, Schiffl H, Cottier C, Reubi FC.
    Kidney Int; 1982 Sep; 22(3):297-303. PubMed ID: 7176332
    [Abstract] [Full Text] [Related]

  • 32. Therapeutic assessment of urapidil or angiotensin-converting enzyme inhibition in systemic hypertension.
    Rosenthal J, Haerlin R.
    Am J Cardiol; 1989 Aug 15; 64(7):25D-29D. PubMed ID: 2667311
    [Abstract] [Full Text] [Related]

  • 33. Prostaglandin E2 analogue elicits renal and hormonal compensatory mechanisms in human hypertension.
    Given BD, Vita NA, Black HR, Francis C, Lasseter K, Morray RL, Mickiewicz C, Akester J, Koury K, Dzau VJ.
    Hypertension; 1986 Jun 15; 8(6):489-96. PubMed ID: 3519451
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Urapidil treatment decreases plasma fibrinogen concentration in essential hypertension.
    Haenni A, Lithell H.
    Metabolism; 1996 Oct 15; 45(10):1221-9. PubMed ID: 8843176
    [Abstract] [Full Text] [Related]

  • 36. [Metabolic and cardiovascular profile in antihypertensive treatment with urapidil].
    Gerber A, Weidmann P, Marone C, Uehlinger D, Riesen W.
    Therapie; 1990 Oct 15; 45 Suppl 2():219-27. PubMed ID: 2187268
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of urapidil and atenolol in hypertension.
    Török E, Wagner M, Podmaniczky M.
    Drugs; 1988 Oct 15; 35 Suppl 6():164-72. PubMed ID: 3042356
    [Abstract] [Full Text] [Related]

  • 38. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
    Ljungman S, Aurell M, Hartford M, Wikstrand J, Berglund G.
    Hypertension; 1983 Oct 15; 5(3):368-74. PubMed ID: 6341220
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of urapidil in the management of essential hypertension. A comparison with captopril.
    Rosenthal J, Haerlin R, Schäfer N, Christ B, Wurst W.
    Drugs; 1988 Oct 15; 35 Suppl 6():147-55. PubMed ID: 3042354
    [Abstract] [Full Text] [Related]

  • 40. Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus.
    Feldt-Rasmussen B, Mathiesen ER, Deckert T, Giese J, Christensen NJ, Bent-Hansen L, Nielsen MD.
    Diabetologia; 1987 Aug 15; 30(8):610-7. PubMed ID: 3653559
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.